Rationale: Cerenkov luminescence imaging (CLI) can provide high resolution images of 18 F-fluorodeoxyglucose (FDG)-avid tumors, but requires prolonged acquisition times due to low photon sensitivity. In this study, we propose a new modality, termed beta-radioluminescence imaging (beta-RLI), which incorporates a scintillator with a gamma rejection strategy for imaging beta particles. We perform a comparative evaluation of beta-RLI with CLI in both in vitro and in vivo systems.
Introduction
Cerenkov luminescence imaging (CLI) is an optical radionuclide imaging technique that can produce high resolution (1-2 mm) functional images of 18 F (1-3) . Since CLI signals demonstrate a strong linear relationship with positron emission tomography (PET) activity (3), this technology can be used for measuring tumor burden after chemotherapy administration (4, 5) and surgical resection (6, 7) . Many radiotracers including 18 F-fluorodeoxyglucose (FDG) are already Federal Drug Administration-approved. As a result, CLI has immediate translational potential, and studies have already been reported in human patients (8) (9) (10) .
However, CLI is limited by its relatively low photon sensitivity.
Investigators have estimated that a 0.635 MeV positron from 18 F can produce only 20 photons with wavelengths between 250-600 nm (1) . As a result, prolonged acquisition times on the order of 3 to 5 minutes in a darkened environment are required (3, 7, 9) . These stringent acquisition conditions may be difficult to satisfy in certain clinical settings, including the operating room.
One potential strategy for improving photon sensitivity is to utilize a scintillator, which can convert beta particles and gamma rays from 18 F into optical light. Scintillators can produce between 1,000 to more than 100,000 photons per MeV depending on the material used (11). Scintillators have been incorporated into handheld radioactive probes and cameras for radioguided surgical applications (12) (13) (14) (15) (16) .
In recent years, non-Cerenkov optical radionuclide imaging techniques, termed radioluminescence imaging (RLI), have been evaluated (17) . In particular, investigators have performed in vitro and in vivo imaging of the pure gamma emitter, 99m Tc, by placing bismuth germanate oxide scintillator crystals between the radioactive source and the camera within a commercial small animal imaging system. The system resolution was 1.3 mm, and a collimator was present (18) . Non-scintillator-based RLI experiments of 99m Tc (19) and an alpha emitter (20) have also been reported.
In our group, one investigator performed RLI of 18 F-FDG-uptake in single cells, by imaging a radioactive cell monolayer in direct contact with a scintillator using microscopy (21) . Another investigator designed a fiberoptic system for imaging 18 F -FDG from ex vivo atherosclerotic plaques that were covered by a scintillator (22) .
In this study, we propose a new method for imaging beta particles from 18 F using a scintillator. This method, termed beta-radioluminescence imaging (beta-RLI), incorporates RLI with a gamma rejection strategy adapted from beta probes (12) . We hypothesize that beta-RLI may provide enhanced photon sensitivity compared with CLI. Furthermore, beta-RLI may produce images of intact 18 F-FDG-avid tumors in a shorter timeframe than that required with CLI. The purpose of this study is to perform a comparative evaluation of beta-RLI with CLI in both in vitro and in vivo settings.
Methods

Materials
18 F-FDG was produced from the radiochemistry facility (Stanford, CA). Two melanoma cell lines, the melanotic B16F10 and amelanotic A375 cell lines, were obtained from the America Type Culture Collection. The head and neck UMSCC1 cell line was obtained from the University of Michigan. The B16F10 and UMSCC1 cell lines were transfected with the pGL4.10[luc2] vector from Promega (Madison, WI) using the jetPRIME transfection reagent (Polyplus, New York, NY), in order to create B16F10-Luc and UMSCC1-Luc cell lines.
Optimal imaging modalities
All images were acquired using an IVIS system (200 or Spectrum) with medium binning and a 10-13 cm imaging field-of-view. Essential acquisition parameters for all imaging modalities are listed in Table 1 . A schematic for beta-RLI is shown in Fig. 1 . Optical imaging modalities are described as follows: 1) CLI: No material was placed between the camera and the object of interest. 2) RLI: A scintillator was positioned ~1 mm above the object, but below the camera.
Optical signals from both beta particles (β) and gamma rays (γ) were collected.
Eqn 1: RLI = β + γ.
3) Block-RLI: A 1 mm-thick stainless steel slab (Evansville Sheet Metal Works, Evansville, IN) was placed between the scintillator and the object.
Stainless steel was utilized because of its ability to block almost all beta particles with energies < 1.5 MeV (12) . The optical signal captured by the camera can be expressed as:
where α 1 and α 2 are the percent beta and gamma transmissions through stainless steel. For this study, estimates of α 1 and α 2 were 0.03 and 0.91, respectively (Supplemental S1). 4) Beta-RLI (with gamma rejection): This image was calculated as the difference between the RLI and block-RLI, which was multiplied by 1/α 2 in order to eliminate the gamma component.
Eqn 3: Beta-RLI = RLI -1/α 2 *block-RLI = β*(1-α 1 /α 2 ).
All RLI and block-RLI were acquired using a radioisotopic screen (Bruker Biosciences Corporation, Billerca, MA), although other scintillators were also evaluated (Supplemental S2).
Optical image processing
Median filtration (3 pixel width) was applied to CLI, RLI, and block-RLI. RLI and block-RLI also underwent additional Gaussian smoothing (sigma = 2 mm) in order to reduce noise. Bias correction, flattening field correction, and cosmic ray correction (median filtration of pixel values more than 10 standard deviations from the image mean) were also applied. All processing was performed using software written in Python 3.2.3 (Python Software Foundation, Beaverton, OR).
In vitro: Signal uniformity
The outer shell of the Micro Deluxe Phantom (Data Spectrum Corp.
Hillsborough, NC) was filled with 20 mL of 1% agarose (Sigma-Aldrich Chemical Co., St. Louis, MO) in order to create a uniform base. A 30 mL solution of 5.1 MBq (137.5 μCi) 18 F-FDG (254 kBq/mL or 6.9 μCi/mL) was prepared. RLI, block-RLI, beta-RLI, and CLI were obtained. Profiles across images were extracted. An additional experiment evaluating signal uniformity over a non-uniform background was also conducted (Supplemental S3).
In vitro: Resolution
A 0.5 mm internal diameter capillary tube (VitroCom, Mountain Lakes, New Jersey) was filled with 18 F-FDG (370 kBq/mL or 10 μCi/mL). Beta-RLI and CLI were acquired with the scintillator placed directly against the capillary tube. Small binning was used. Profiles were drawn perpendicular to the capillary tube, and full-width half maximum (FWHM) values were extracted.
In vitro: Object-scintillator distance dependencies for beta-RLI
A 0.5 mm diameter capillary tube was filled with 259 kBq/mL (7 μCi/mL) 18 F-FDG, and positioned on a stack of ten 1 mm thick acrylic slabs. Serial beta-RLI images were acquired at distances between the capillary tube and scintillator of 1-10 mm. FWHM values and maximum signal ratios (maximal signal at specified distance/maximal signal at 1 mm distance for air) from profiles drawn perpendicular to the capillary tube were acquired for these air distances. In order to evaluate depth dependency, maximum signal ratios were also acquired for a capillary tube placed under 1-3 mm of acrylic. 
In vitro: Photon sensitivity analysis
In vivo: PET imaging
PET images were acquired using a microPET/CT scanner (Inveon, Siemens Medical Solutions USA, Inc, Knoxville, TN). Tumor-bearing animals were injected with 11.1-14.8 MBq (300-400 μCi) 18 F-FDG dissolved in 150 μL PBS via the tail vein. After 30-60 minutes, mice were anesthetized with 2% isoflurane (Aerrane' Baxter, Deerfield, IL), positioned in the prone position, and imaged. PET images were reconstructed using the ordered subsets expectation maximum algorithm with attenuation correction if CT data were available. Tumor activities were quantified using commercial software.
In vivo: Optical imaging
Acquisition times were 300 seconds for CLI, and 10 seconds for both RLI and block-RLI. For CLI, 1-3 mice were imaged at the same time. For beta-RLI, one mouse was imaged each time. BLI was acquired over 60 seconds at 10 minutes after intraperitoneal injection of D-Luciferin (150 mg/kg).
• Melanotic B16F10-Luc (n = 14): After tumor exposure (skin excision), beta-RLI and CLI were acquired. Given negative tumor contrast with CLI, BLI was performed and mice were sacrificed. After confirming that photons from BLI did not pass through the scintillator (data not shown), beta-RLI was performed after partial and full resections for 5 and 10 mice, respectively. After full resection, BLI was acquired for evaluating the presence of residual disease. CLI was not performed after partial and full resections due to the presence of D-Luciferin.
• Amelanotic A375 (n = 5): Beta-RLI and CLI were acquired after tumor exposure, partial resection, and full resection. Mice were not repositioned between beta-RLI and CLI. Mice were sacrificed after initial imaging of the exposed tumors.
• Amelanotic UMSCC1-Luc (n = 13): After tumor exposure, beta and CLI were acquired for 13 and 4 mice, respectively. Mice were then sacrificed.
In vivo: Tumor signal-to-background ratio
Tumor ROIs were delineated using white-light and functional (CLI, RLI, beta-RLI, and BLI) images using ITK-SNAP 3.0 software (23) . Background ROIs were drawn around the tumor ROI using a circular tool with a diameter of 4-6 mm. However, regions covering intact skin were excluded. Tumor signalbackground ratios (SBRs) were then computed.
In vivo: Statistical analysis
The following analyses were conducted:
1. Pearson's correlation coefficients between 18 F-FDG PET activity (scaled to the time of optical imaging) and tumor radiance after tumor exposure were calculated for beta-RLI, CLI for amelanotic tumors, and CLI for melanotic tumors. Fig. 2 shows RLI, block-RLI, beta-RLI, and CLI of the cylinder with 18 F-FDG. As exhibited in the profiles, the elevated background in the RLI was suppressed in the beta-RLI. However, the resulting beta-RLI was not nearly as uniform as CLI. In another experiment, beta-RLI was effective in suppressing gamma rays from a non-uniform background (Supplemental S3).
Results
In vitro experiments
As shown in Fig. 3a , maximum signal ratios degraded as the air distance between the scintillator and the capillary tube increased.
Furthermore, marked declines in maximum signal ratios were observed at 1-3 mm depths below the acrylic slabs. With respect to resolution, the FWHM values of profiles perpendicular to the 0.5 mm capillary source were 1.0 mm for CLI and 4.4 mm for beta-RLI when the scintillator was placed against the capillary tube. Fig. 3b shows that the beta-RLI resolution decreased, as the distance between the scintillator and the capillary tube increased. Fig. 3c depicts intensity values for serial FDG dilutions. Photon sensitivity values for beta-RLI and CLI were 391.8 p/s/cm 2 /sr/Bq (37.3 counts per second (cps)/kBq) and 0.7 p/s/cm 2 /sr/Bq (0.07 cps/kBq) respectively. Beta-RLI was 560 times more sensitive than CLI based on this experiment. Beta-RLI also exhibited greater photon sensitivity in imaging B16F10 cells (Supplemental S4). 
In-vivo studies: Tumor exposure
In-vivo studies: Serial resections
In-vivo studies: Residual disease after full resection
All 10 mice that underwent full resections of B16F10-Luc tumors had residual disease based on BLI. The median SBR was 1.0 [minimum 0.8, maximum 1.6]. Four of 10 tumors (40%) had an SBR > 1.2, and appeared discernible from background in Fig. 7 . The other six tumors were not easily discernible.
Discussion:
In this study, we evaluated a method for the functional imaging of 18 Using in vivo mouse models, we demonstrated statistically significant correlations between 18 F-FDG activity and radiance for amelanotic lesions using beta-RLI and CLI, but not for melanotic lesions using CLI. Furthermore, 9 of 13 melanotic lesions had an SBR < 1 for CLI, despite an SBR > 1 among all lesions for beta-RLI. These results suggest that Cerenkov photons were absorbed by melanin. However, beta-RLI images often exhibited high background signal after resection, especially for surrounding structures closer to the scintillator (see Fig. 6 ). Furthermore, CLI may provide a more quantitative assessment of tumor burden, as demonstrated by the statistically significant declines in SBR after both partial and full resections of the A375 tumors. Lastly, beta-RLI is not suitable for imaging microscopic disease, as only 4 of 10 B16F10-Luc tumors with microscopic residual disease had an SBR > 1.2. Although CLI was not evaluated in this manner, its photon sensitivity is likely insufficient for evaluating microscopic disease (Supplemental S4).
The imaging properties for beta-RLI and quite similar to those for beta probes/cameras. With respect to photon sensitivity, a beta prototype utilizing a phoswich detector for electronic gamma rejection exhibited lower photon sensitivity (2.5-14.0 cps/kBq depending on collimation) (14) than this beta-RLI system (37.3 cps/kBq). However, beta prototypes utilizing the gamma subtraction technique that was adapted for beta-RLI demonstrated a greater photon sensitivity (>100 cps/kBq) (12, 13, 16) . Beta prototypes have a similar spatial resolution (1.6-5 mm) (13, 15, 16) , as well as limited depth penetration (16) . Furthermore, beta probes also exhibit decreasing signal intensity and spatial resolution with increasing object-scintillator distance (14, 15) .
However, over the past two decades, beta probes have undergone intensive experimental and clinical evaluations for 18 F-FDG guided surgery.
Experimental studies suggest that beta probes offer superior real-time localization of tumor deposits compared with gamma probes (24, 25) . In addition, clinical studies for the intraoperative tumor localization of melanomas (13) and other cancers (15, 26) have yielded promising results.
Given the parallels between beta-RLI and beta probes/cameras, we would expect 18 F-FDG-guided surgery to be the main clinical application for beta-RLI. However, beta-RLI has potential advantages over beta probes/cameras. First, beta-RLI has optical image overlay, which can allow the surgeon to correlate areas of increased activity with anatomic features.
Second beta-RLI can provide a large imaging field-of-view for efficient functional mapping of the operative bed.
There are other methods for improving the sensitivity of CLI without scintillators. Down-conversion involves utilizing nanoparticles to shift the wavelength of Cerenkov light for better tissue penetration (27) . However, Table 2 : Signal-background ratios (SBRs) for amelanotic A375 (n = 5) tumors and melanotic B16F10-Luc (n = 5) tumors after tumor exposure, partial resection, and full resection. SD is standard deviation. * denotes statistically significant declines in tumor SBR after partial and full resections, based on a one-sided t-test (p < 0.05).
